Brokerages have initiated coverage on seven Indian stocks, including Groww, Suzlon, and VA Tech Wabag, with potential upside ranging up to 28%. Analysts are bullish on these companies, citing strong growth prospects in sectors like retail investing, renewable energy, and water management, expecting significant returns from current market levels.Read More
Shares of Anthem BioSciences rose after Citi initiated coverage with a Buy rating and a target price of ₹870, implying over 20% upside. Analysts cited strong growth prospects, a robust portfolio of commercial molecules, sticky client relationships, and scalable manufacturing capabilities supporting long-term revenue visibility.Read More
Nelco shares rose sharply on Tuesday after the company swung to a Q4 net profit of Rs 1.09 crore from a loss last year. Revenue rose 17%, boosting sentiment despite full-year profit pressure. FPIs and institutional investors also increased their stakes during the March quarter.Read More
US regulators have proposed easing disclosure norms for the private fund industry to reduce compliance burdens while retaining key data for monitoring financial stability. The revised framework raises reporting thresholds but is expected to still cover most assets. The proposal has drawn mixed reactions from industry bodies and regulatory advocacy groups.Read More
Deepak Shenoy of Capitalmind MF sees cautious optimism in Indian equities. His fund is gradually investing cash, looking for opportunities across all market sizes. Shenoy is watching sectors like defence, industrials, and manufacturing. He expects the upcoming earnings season to reveal both positive surprises and some challenging realities for companies.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.
